Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: A qualitative interview study.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
04 2019
Historique:
received: 24 10 2018
revised: 18 12 2018
accepted: 21 01 2019
pubmed: 30 1 2019
medline: 25 2 2020
entrez: 30 1 2019
Statut: ppublish

Résumé

The incidence of lung cancer is four times higher in people with chronic obstructive pulmonary disease (COPD) compared with the general population. Promotion of a shorter time from symptom onset to presentation is one potential strategy for earlier lung cancer diagnosis, but distinguishing respiratory symptoms can be difficult. We investigated how the experience of COPD influences symptom appraisal and help seeking for potential lung cancer symptoms. We conducted qualitative interviews with men (n = 17) and women (n = 23) aged 40 to 83 years with COPD. Topic guides drew on the integrated symptom-response framework and covered symptom experience, interpretation, action, recognition, help seeking, evaluation, and reevaluation. We used the framework method to analyse the data. Participants said that they attributed chest symptoms to their COPD; no other cause was considered. Participants said that family/friends noticed changes in their symptoms and encouraged help seeking. Others felt isolated by their COPD because they could not get out, were fatigued, or were embarrassed. Participants visited health professionals frequently, but increased risk of lung cancer was not discussed. Our study provides insight into different levels of influence on symptom appraisal and targets for intervention. Greater awareness of increased lung cancer risk and support to act on symptom changes is essential and could be achieved through a concerted information campaign. Health professionals working with people with COPD could also optimise appointments to support symptom appraisal of potential lung cancer symptoms.

Identifiants

pubmed: 30693608
doi: 10.1002/pon.5005
pmc: PMC6492269
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

718-725

Subventions

Organisme : Cancer Research UK
ID : C9227/A21572
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd.

Références

Thorax. 2009 Jun;64(6):523-31
pubmed: 19052045
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2127-31
pubmed: 21876191
Psychooncology. 2019 Apr;28(4):718-725
pubmed: 30693608
Psychol Health. 2010 Dec;25(10):1229-45
pubmed: 20204937
Br J Gen Pract. 2013 Jan;63(606):e47-54
pubmed: 23336469
Br J Gen Pract. 2014 Dec;64(629):e775-82
pubmed: 25452542
Patient Educ Couns. 2001 Feb;42(2):145-57
pubmed: 11118780
Thorax. 2012 May;67(5):426-32
pubmed: 22426791
BMJ Open Respir Res. 2014 Dec 11;1(1):e000067
pubmed: 25553249
Soc Sci Med. 2017 Oct;191:134-142
pubmed: 28917622
Br J Cancer. 2017 Jun 6;116(12):1536-1543
pubmed: 28494470
Eur Respir J. 2009 Aug;34(2):380-6
pubmed: 19196816
Soc Sci Med. 2013 Jun;86:79-87
pubmed: 23608096
Br J Gen Pract. 2016 Jul;66(648):e474-82
pubmed: 27215569
Br J Gen Pract. 2015 Feb;65(631):e96-e105
pubmed: 25624313
Thorax. 2005 Apr;60(4):268-9
pubmed: 15790977
Soc Sci Med. 2017 Mar;176:113-122
pubmed: 28135690
Thorax. 2005 Apr;60(4):314-9
pubmed: 15790987
BMJ Open. 2016 Dec 8;6(12):e011555
pubmed: 27932338
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
BMJ Open. 2015 May 18;5(5):e008046
pubmed: 25986641
Br J Cancer. 2015 Mar 31;112 Suppl 1:S6-13
pubmed: 25734397
Br J Gen Pract. 2013 Jan;63(606):e37-46
pubmed: 23336459
Br J Soc Psychol. 1995 Mar;34 ( Pt 1):33-52
pubmed: 7735731

Auteurs

Yvonne Cunningham (Y)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Sally Wyke (S)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Kevin G Blyth (KG)

Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.
Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.

Douglas Rigg (D)

Keppoch Medical Practice, Possilpark Health & Care Centre, Glasgow, UK.

Sara Macdonald (S)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Una Macleod (U)

Faculty of Health Sciences, Hull York Medical School, Hull, UK.

Stephen Harrow (S)

PET/CT Centre, Beatson West of Scotland Cancer Centre, Glasgow, UK.

Kathryn A Robb (KA)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Katriina L Whitaker (KL)

School of Health Sciences, University of Surrey, Guildford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH